The agreement follows Insilico's previous collaboration with Meyer Chroma Technology
Insilico Biotechnology and 2-control are collaborating to control and optimise individual digital twins for the ‘smart biofactory’ concept.
Insilico provides customers with predictive digital twins for process development and manufacturing. Recently, through a collaboration with Meyer Chroma Technology, Insilico has added digital twins for purification to its product portfolio. Now the company has announced the alliance with 2-control ApS to create plant-wide control of the individual digital twins as well as the entire digital value chain.
2-control, based in Copenhagen, Denmark, supplies control and optimisation for industrial processes. The combination of 2-control’s model predictive control with Insilico digital twins aims to provide possibilities for customers to monitor, control and optimise performance, robustness as well as product quality, both for the individual digital twins and for the entire system.
Klaus Mauch, CEO of Insilico, said: "Insilico is looking forward to working with 2-control. By controlling the individual Digital Twins as well as the entire system, it will be possible to take process performance and process robustness of our customers' bio-production to a new level."
Prof John Bagterp Jorgensen, CEO of 2-control, added: "The collaboration with Insilico opens up new, exciting areas of application in biotechnological process development and production. The biotechnological industry will greatly benefit from our many years of experience with complex industrial processes".